(Q36485658)

14 August 2017

1 reference

title

Research in child and adolescent psychopharmacology: recent accomplishments and new challenges (English)

1 reference

14 August 2017

1 reference

1

Benedetto Vitiello

1 reference

14 August 2017

publication date

23 May 2006

1 reference

14 August 2017

number of pages

9

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

14 August 2017

volume

191

1 reference

14 August 2017

issue

1

1 reference

14 August 2017

page(s)

5-13

1 reference

Valproic acid hepatic fatalities. III. U.S. experience since 1986.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0414-3

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0414-3

Treatment of ADHD in children with tics: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0414-3

Medication development and testing in children and adolescents. Current problems, future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0414-3

Psychotropic practice patterns for youth: a 10-year perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0414-3

Psychiatry as a clinical neuroscience discipline

21 January 2018

1 reference

12 December 2020

How can we improve the assessment of safety in child and adolescent psychopharmacology?

1 reference

12 December 2020

Lifetime Prevalence and Age-of-Onset Distributions of DSM-IV Disorders in the National Comorbidity Survey Replication

1 reference

12 December 2020

ADHD drugs and cardiovascular risk

1 reference

12 December 2020

The case for practical clinical trials in psychiatry

1 reference

12 December 2020

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

1 reference

12 December 2020

Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood

1 reference

12 December 2020

Sertraline pharmacokinetics and dynamics in adolescents

1 reference

12 December 2020

National trends in the use of psychotropic medications by children

1 reference

12 December 2020

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

1 reference

12 December 2020

The Pediatric Pharmacology Research Unit (PPRU) Network and its role in meeting pediatric labeling needs.

1 reference

12 December 2020

Fluoxetine pharmacokinetics in pediatric patients

1 reference

12 December 2020

Suicidal adverse events in pediatric randomized, controlled clinical trials of antidepressant drugs are associated with active drug treatment: a meta-analysis

1 reference

12 December 2020

Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Psychotropic co-medication among stimulant-treated children in The Netherlands

1 reference

12 December 2020

ADHD is best understood as a cultural construct

1 reference

12 December 2020

Incidence of autism spectrum disorders: Changes over time and their meaning*

1 reference

12 December 2020

A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD

1 reference

12 December 2020

Hyperactivity and conduct problems as risk factors for adolescent development

1 reference

12 December 2020

Stimulant treatment for children: a community perspective.

1 reference

12 December 2020

Antidepressant use in children and adolescents in Germany

1 reference

12 December 2020

Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?

1 reference

12 December 2020

The Maudsley long-term follow-up of child and adolescent depression

1 reference

12 December 2020

National estimates of antidepressant medication use among U.S. children, 1997-2002.

1 reference

12 December 2020

Paroxetine pharmacokinetics in depressed children and adolescents.

1 reference

12 December 2020

Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government

1 reference

12 December 2020

Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample

1 reference

12 December 2020

Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder

1 reference

12 December 2020

Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

1 reference

12 December 2020

Attention-deficit/hyperactivity disorder pharmacogenomics

1 reference

12 December 2020

Antidepressants and pediatric depression--the risk of doing nothing

1 reference

12 December 2020

Cost-effectiveness of ADHD treatments: findings from the multimodal treatment study of children with ADHD

1 reference

12 December 2020

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

1 reference

12 December 2020

Effects of the Committee on Safety of Medicines advice on antidepressant prescribing to children and adolescents in the UK.

1 reference

12 December 2020

Prevalence and development of psychiatric disorders in childhood and adolescence

1 reference

12 December 2020

US biomedical research: basic, translational, and clinical sciences

1 reference

12 December 2020

Recent trends in stimulant medication use among U.S. children

1 reference

12 December 2020

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

1 reference

12 December 2020

Cytogenetic effects in children treated with methylphenidate

1 reference

12 December 2020

The Child and Adolescent Psychiatry Trials Network (CAPTN).

1 reference

12 December 2020

Review of safety assessment methods used in pediatric psychopharmacology

1 reference

12 December 2020

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

1 reference

12 December 2020

The interface between publicly funded and industry-funded research in pediatric psychopharmacology: opportunities for integration and collaboration

1 reference

12 December 2020

Young adult follow-up of hyperactive children: antisocial activities and drug use

1 reference

12 December 2020

Another sudden death in a child treated with desipramine

1 reference

12 December 2020

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities

1 reference

12 December 2020

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

1 reference

12 December 2020

Pemoline hepatotoxicity and postmarketing surveillance

1 reference

12 December 2020

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD

1 reference

12 December 2020

Tricyclic drugs for depression in children and adolescents.

1 reference

12 December 2020

Phenobarbital for febrile seizures--effects on intelligence and on seizure recurrence

1 reference

12 December 2020

Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).

1 reference

12 December 2020

A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents

1 reference

12 December 2020

Comments on 'Cytogenetic effects in children treated with methylphenidate' by El-Zein et al.

1 reference

12 December 2020

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

1 reference

12 December 2020

Off-label uses of drugs in children.

1 reference

12 December 2020

Depressed Adolescents Grown Up

1 reference

12 December 2020

Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine

1 reference

12 December 2020

Treatment guidelines for children and adolescents with bipolar disorder

1 reference

12 December 2020

Excess fatality from desipramine in children and adolescents

1 reference

12 December 2020

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

1 reference

12 December 2020

Young adult outcome of hyperactive children: adaptive functioning in major life activities

1 reference

12 December 2020

Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders

1 reference

12 December 2020

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

1 reference

12 December 2020

Suicidality in pediatric patients treated with antidepressant drugs

1 reference

12 December 2020

Risperidone in children with autism and serious behavioral problems

1 reference

12 December 2020

Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents

1 reference

12 December 2020

Estimation of the association between desipramine and the risk for sudden death in 5- to 14-year-old children

1 reference

12 December 2020

An update on publicly funded multisite trials in pediatric psychopharmacology.

1 reference

12 December 2020

The early stages of schizophrenia: speculations on pathogenesis, pathophysiology, and therapeutic approaches

1 reference

12 December 2020

Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder

1 reference

12 December 2020

Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature

1 reference

12 December 2020

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

12 December 2020

Enduring behavioral effects of early exposure to methylphenidate in rats

1 reference

12 December 2020

Comparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacology

1 reference

12 December 2020

10.1007/S00213-006-0414-3

Identifiers

DOI

1 reference

release_xe346untyzaqloamm7ldpiqksq

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xe346untyzaqloamm7ldpiqksq

24 November 2022

mapped directly with Wikidata item

1 reference